Health news, medical discoveries and wellness tips
A novel drug patch developed at Mainz University, delivering low-dose theophylline, is moving towards clinical trials for multiple sclerosis. The patch aims to promote myelin sheath repair, a process currently lacking effective therapies, with €1.1 million in new funding.
A pilot study in Frontiers in Nutrition reveals that a personalized elimination diet, guided by IgG food sensitivities, significantly altered gut bacteria and reduced zonulin levels in migraine sufferers. This suggests a potential link between gut health and migraine symptom reduction.
Groundbreaking research suggests many breast cancer survivors with treatment-induced heart issues can safely discontinue lifelong heart medication once their heart function recovers. A trial found 98% maintained heart health after stopping drugs, with improved quality of life.
Medicare's pilot GLP-1 discount program offers $50 monthly access to weight-loss drugs but excludes patients with certain qualifying medical conditions, leaving many, like Jeff La Marca with severe sleep apnea, unable to afford crucial treatments despite significant health risks.
A new study reveals the profound impact of 96 bridges built in Rwanda by nonprofit Fika since 2020. These structures, costing around $100,000 each, have significantly boosted household income, agricultural output, and school attendance, while reducing travel time and improving access to vital services like healthcare. The research highlights the immense return on investment for such infrastructure projects in challenging terrains.
A large study suggests long-term melatonin use in chronic insomnia patients may increase heart failure risk by 90%. Researchers caution findings are preliminary and don't prove causation, highlighting the need for more research on the popular supplement's cardiovascular safety.
Children of centenarians exhibit significantly lower risks of death, heart disease, and hypertension, suggesting a genetic component to healthy aging. Study highlights potential for new longevity treatments.
A study in Nature Aging reveals the cancer gene CCND1, known for driving cell division, also fuels chronic inflammation in senescent ('zombie') cells. This discovery opens avenues for therapies targeting age-related diseases by repurposing drugs like palbociclib.
A UK study found mycotoxins in every plant-based meat alternative and beverage tested. While levels are below EU guidelines, researchers caution about potential long-term cumulative exposure from a diet rich in these products.